Shamwari:
Asset Type:
Partner Background:
Kudyidzana Details:
Shamwari:

Asset Type:
Immuno-Oncology
Partner Background:
Yuhan Corporation ndeimwe yemakambani makuru ekuKorea emishonga, yakavambwa makore anopfuura makumi masere apfuura
Kudyidzana Details:
Joint Venture inonzi ImmuneOncia Therapeutics, LLC
Yakatarisana nekugadzira uye kushambadzira akati wandei emasoja ekudzivirira ezvirwere zvehematological malignancies uye mamota akasimba.
Shamwari:

Asset Type:
Immuno-Oncology
Partner Background:
Lee's Pharm ikambani yeruzhinji biopharma ine makore anopfuura makumi maviri ekushanda muChina uye parizvino inotengesa zvigadzirwa gumi nemana muPRC.
Kudyidzana Details:
Sorrento ine mvumo yakasarudzika kuLee's Pharm yekugadzira uye kushambadzira iyo yakazara vanhu anti-PD-L1 mAb STI-A1014 yemusika mukuru weChinese.
Shamwari:

Asset Type:
Serura Therapy
Partner Background:
Celularity is spin-off kubva kuCelgene Corporation inotarisa pa placenta-yakatorwa uye tambo-yeropa inotorwa maseru kurapwa.
Kudyidzana Details:
Equity Investment uye Bhodhi Representation
Shamwari:

Asset Type:
Immuno-oncology
Partner Background:
MABPHARM ikambani yebiopharma inotarisa kuR & D nekugadzirwa kwemishonga mitsva uye "Biobetters" yegomarara nezvirwere zve autoimmune.
Kudyidzana Details:
Sorrento ine rezinesi rakasarudzika rekutengesa maBiobetter mana apedza zvidzidzo zveChikamu 3 muChina kumisika yeNorth America, Europe neJapan.
PaSorrento, isu tinotsvaga kudyidzana kwakasimba uye kubatana semutyairi akakosha wezano redu kusundira miganhu yesainzi uye kuendesa marara-anoshandura marapirwo kuvarwere kuti vararame hupenyu hwakanaka uye hunofadza.


